Validation of an LC-MS/MS Method for Urinary Lactulose and Mannitol Quantification: Results in Patients with Irritable Bowel Syndrome

<div class="floats-full-page floats-full-page-other"><h2>Table 3</h2><div class="floats-full-page-caption">L/M ratio of each urinary sample of controls and patients.</div><div class="floats-full-page-content"><table class="table-group" id="tab3"><tr><td><table class="table"><tr><td class="thead-hr" colspan="4"><hr /></td></tr><tr class="thead"><td class="align_left">Controls</td><td class="align_center">L/M ratio</td><td class="align_center">IBS</td><td class="align_center">L/M ratio</td></tr><tr><td class="thead-hr" colspan="4"><hr /></td></tr><tr><td class="align_left">1</td><td class="align_center">0.010</td><td class="align_center">1</td><td class="align_center">0.307</td></tr><tr><td class="align_left">2</td><td class="align_center">0.010</td><td class="align_center">2</td><td class="align_center">0.054</td></tr><tr><td class="align_left">3</td><td class="align_center">0.009</td><td class="align_center">3</td><td class="align_center">0.115</td></tr><tr><td class="align_left">4</td><td class="align_center">0.029</td><td class="align_center">4</td><td class="align_center">0.018</td></tr><tr><td class="align_left">5</td><td class="align_center">0.014</td><td class="align_center">5</td><td class="align_center">0.083</td></tr><tr><td class="align_left">6</td><td class="align_center">0.019</td><td class="align_center">6</td><td class="align_center">0.029</td></tr><tr><td class="align_left">7</td><td class="align_center">0.008</td><td class="align_center">7</td><td class="align_center">0.187</td></tr><tr><td class="align_left">8</td><td class="align_center">0.016</td><td class="align_center">8</td><td class="align_center">0.041</td></tr><tr><td class="align_left">9</td><td class="align_center">0.009</td><td class="align_center">9</td><td class="align_center">0.022</td></tr><tr><td class="align_left">10</td><td class="align_center">0.011</td><td class="align_center">10</td><td class="align_center">0.047</td></tr><tr><td class="align_left"> </td><td class="align_center"> </td><td class="align_center">11</td><td class="align_center">0.068</td></tr><tr><td class="align_left"> </td><td class="align_center"> </td><td class="align_center">12</td><td class="align_center">0.093</td></tr><tr><td class="align_left"> </td><td class="align_center"> </td><td class="align_center">13</td><td class="align_center">0.141</td></tr><tr><td class="align_left"> </td><td class="align_center"> </td><td class="align_center">14</td><td class="align_center">0.080</td></tr><tr><td class="align_left"> </td><td class="align_center"> </td><td class="align_center">15</td><td class="align_center">0.0161</td></tr><tr class="table-tr"><td colspan="4"><hr class="tbody-hr" /></td></tr></table></td></tr></table></div></div>

Table 3 | Validation of an LC-MS/MS Method for Urinary Lactulose and Mannitol Quantification: Results in Patients with Irritable Bowel Syndrome

title

Table 3: Validation of an LC-MS/MS Method for Urinary Lactulose and Mannitol Quantification: Results in Patients with Irritable Bowel Syndrome

description

Table 3

About this journal

<p><em>Disease Markers</em> publishes papers related to the identification of disease markers, the elucidation of their role and mechanism, as well as their application in the prognosis, diagnosis and treatment of diseases.</p>


Journal profile

Meet the editorial board

<p><em>Disease Markers</em> maintains an Editorial Board of practicing researchers from around the world, to ensure manuscripts are handled by editors expert and up-to-date in the field of study.</p>


Editor spotlight

Submit to Special Issue

We currently have a number of Special Issues open for submission. Special Issues highlight emerging areas of research within a field, or provide a venue for a deeper investigation into an existing research area.